Jonathan Tamblyn Joins Skolem Technologies as Chief People Officer
Former Head of Talent at Gemini Brings Nearly 15 Years of Experience in Talent Development,…
Former Head of Talent at Gemini Brings Nearly 15 Years of Experience in Talent Development,…
Funding will further develop the capacity for Agrology’s MRV platform to quantify climate-smart practices in…
NEW YORK–(BUSINESS WIRE)–Cadence today announced a partnership with Ardent Health Services to implement a remote…
Industry veteran assumes strategic direction and oversight of Janney’s comprehensive advice and solutions platform PHILADELPHIA–(BUSINESS…
InterSystems IRIS data platform remains ahead of industry curve and is a solution that consistently…
JUMP 2.0, led by the Semiconductor Research Corporation, expands collaboration in new program spanning 7…
ProcureTech Selected Zip for Its Seamless, Consumer-grade User Experience That Eases Procurement Challenges for the…
Increases Global Accessibility and Enhances User Capabilities SAN FRANCISCO–(BUSINESS WIRE)–Planet Labs PBC (NYSE: PL), a…
Intelligent cellular solutions leader provides flexible entry into private networking for manufacturing, distribution, warehousing, and…
NEW YORK–(BUSINESS WIRE)–Catalyst Advisors LP, an international executive recruitment and assessment firm singularly focused on…
Project Aims to Sequester Initial 370,000 Metric Tons of CO2 Per Annum LONG BEACH, Calif.–(BUSINESS…
ST. LOUIS–(BUSINESS WIRE)–Frontline Managed Services, the leading global provider of outsourced solutions to over 600…
Positive and clinically meaningful pivotal clinical results announced in 2022 in both metastatic and locally…
Helsinn publishes results from a secondary analysis of a Phase 3 trial in patients with…
REDWOOD CITY, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…
BALTIMORE, Jan. 04, 2023 (GLOBE NEWSWIRE) — Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused…
NEW YORK and LONDON, Jan. 04, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or…
CBO-212 is a first-in-class inhibitor of CD73 cancer immunotherapy target SAN DIEGO, Jan. 04, 2023…
SAN DIEGO, Jan. 04, 2023 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision…